Milestone Scientific Inc. MLSS
Nov 4, 2026, 9:30 AM EST
- YTD
- +12.56%
- 1 year
- -27.64%
- Market cap
- 27.54M
- Revenue (ttm)
- 8.42M
- Profit margin
- -54.88%
- EPS (ttm)
- -0.04
- Shares out
- 77.89M
- Forward P/E
- -21.75
- YTD return
- +12.56%
- 1-year return
- -27.64%
- Volume
- 7.45K
- Avg volume
- 116.25K
- Open
- 0.332
- Previous close
- 0.3039
- Day's range
- 0.3039 – 0.3417
- 52-week range
- 0.22 – 0.58
- Beta
- 1.08
- Price target
- 2.13 (+599.2%)
5D +0.0060 (+2.01%)
Key statistics
- Enterprise value
- 44.83M
- PEG ratio
- 0.00
- Price / sales
- 8.05
- Price / book
- 8.21
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- -36.30%
- Free cash flow
- -2.74M
- Total cash
- 5.75M
- Total debt
- 340.44K
- Return on equity
- -59.40%
- Short % of float
- 0.19%
- 50-day average
- 0.8096
- 200-day average
- 0.7983
Analyst view
- Target (low)
- 1.25
- Target (mean)
- 2.13
- Target (high)
- 3.00
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.01.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 14, 2024 | Sep 1, 2024 | 0.00 | -0.02 | — | — |
| Aug 14, 2024 | Jun 1, 2024 | 0.00 | 0.00 | — | — |
| May 15, 2024 | Mar 1, 2024 | 0.00 | -0.02 | — | — |
| Mar 29, 2024 | Dec 1, 2023 | 0.00 | -0.03 | — | — |
| Nov 14, 2023 | Sep 1, 2023 | 0.00 | -0.02 | — | — |
| Aug 15, 2023 | Jun 1, 2023 | 0.00 | -0.03 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 20, 2024 | Benchmark | reit | Speculative Buy | Speculative Buy |
| Oct 10, 2024 | Benchmark | init | — | Speculative Buy |
About Milestone Scientific Inc.
Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- milestonescientific.com
News
Milestone Scientific Provides Major Commercial Growth Update as CompuFlo® Expands Across 30 Million+ Annual Global Epidural Procedures 
12 Health Care Stocks Moving In Monday's After-Market Session 
12 Health Care Stocks Moving In Friday's Pre-Market Session 
Why Synaptics Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket 
12 Health Care Stocks Moving In Monday's After-Market Session 
Milestone Scientific Directors Convert $465K Loans Into Equity, Eliminating Debt And Achieving Debt‑Free Balance Sheet - 12 Health Care Stocks Moving In Friday's After-Market Session
Conference Call:
Milestone Scientific Affirms FY2026 Sales Guidance of $9.800M-$10.200M vs $9.910M Est - Transcript: Milestone Scientific Q2 2026 Earnings Conference Call
Milestone Scientific Q2 EPS $(0.01), Inline, Sales $2.841M Beat $2.700M Estimate
Your note
Sign in to keep a note on MLSS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CASAMENTO BENEDETTA I. | Director | Stock Award(Grant) | Aug 27, 2024 | 404,491 |
| GOLDMAN NEAL I | Director | Stock Award(Grant) | Aug 27, 2024 | 1,905,860 |
| HAVERHALS JAN ADRIAAN | President | Stock Award(Grant) | May 16, 2023 | 319,546 |
| MCGEEHAN MICHAEL | Director | Sale | Dec 18, 2024 | 575,273 |
| MILLIGAN PETER J | President | Stock Award(Grant) | Jul 31, 2023 | 124,421 |
| OSSER LEONARD A | Director | Sale | Oct 21, 2024 | 4,606,880 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 2.80% | 2,179,684 | 1.90M | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.68% | 527,005 | 458.49K | Sep 29, 2024 |
| Bridgeway Capital Management, Inc. | 0.52% | 401,700 | 349.48K | Sep 29, 2024 |
| Carnegie Investment Counsel | 0.19% | 145,197 | 126.32K | Sep 29, 2024 |
| Mariner, LLC | 0.16% | 121,750 | 105.92K | Sep 29, 2024 |
| State Street Corporation | 0.15% | 117,785 | 102.47K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.90% | 1,482,454 | 1.29M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.83% | 644,906 | 561.07K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.38% | 292,991 | 254.90K | Oct 30, 2024 |
| Bridgeway Funds Inc-Ultra Small Company Fund | 0.31% | 243,700 | 212.02K | Sep 29, 2024 |
| Bridgeway Funds Inc-Ultra Small Company Market Fund | 0.19% | 149,500 | 130.06K | Sep 29, 2024 |
| Fidelity Total Market Index Fund | 0.13% | 103,227 | 89.81K | Oct 30, 2024 |